Genitourinary Cancer

Risk Factors for UTUC Intravesical Recurrence Identified

By

Jody A. Charnow, Editor

Publish Date March 16, 2020

Larger tumor size and more advanced tumor stage are associated with an increased risk of intravesical recurrence among patients undergoing radical nephroureterectomy for in upper tract urothelial carcinoma.

POUT Trial May Lead to New Standard of Care for UTUC

By

Natasha Persaud

Publish Date March 13, 2020

Adjuvant platinum-based chemotherapy for upper tract urothelial carcinoma within 90-days of nephroureterectomy improves disease-free and metastasis-free survival compared with surveillance, a study found.

Combination Therapy for Advanced Urothelial Carcinoma Shows Promise in Early Clinical Trial

By

Victoria Forster, PhD

Publish Date February 25, 2020

A combination of pembrolizumab and an antibody-drug conjugate demonstrated a 73% overall response rate in a phase 1/2 clinical trial.

Screening for Frailty May Improve Outcomes for Older Patients With Genitourinary Malignancies

By

John Schieszer

Publish Date February 19, 2020

The VES-13, a brief frailty screening tool, was found effective in determining which older patients with GU cancer were at higher risk for adverse outcomes and would benefit from a CGA.

Use of Palliative Care in Managing Genitourinary Malignancies May Vary Across the United States

By

John Schieszer

Publish Date February 19, 2020

Patients with GU malignancies were more likely to receive palliative care if they were in the West compared with other US regions.